Novo Nordisk Aktie
85,65
EUR
+3,59
EUR
+4,37
%
83,42
EUR
+4,22
EUR
+5,33
%
Novo Nordisk Aktie Analyse
| 16.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.10.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 09.10.20 | Novo Nordisk Neutral | UBS AG | |
| 09.10.20 | Novo Nordisk Verkaufen | DZ BANK | |
| 09.10.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 29.09.20 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.09.20 | Novo Nordisk Neutral | UBS AG | |
| 18.08.20 | Novo Nordisk Neutral | UBS AG | |
| 14.08.20 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 11.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 07.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.08.20 | Novo Nordisk Outperform | Bernstein Research | |
| 07.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.08.20 | Novo Nordisk Neutral | UBS AG | |
| 06.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.08.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 06.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.07.20 | Novo Nordisk Neutral | UBS AG | |
| 16.07.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.07.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 22.06.20 | Novo Nordisk Neutral | Oddo BHF | |
| 18.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 16.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 15.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.06.20 | Novo Nordisk Neutral | UBS AG | |
| 21.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.05.20 | Novo Nordisk Neutral | UBS AG | |
| 14.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.05.20 | Novo Nordisk Neutral | UBS AG | |
| 07.05.20 | Novo Nordisk overweight | Barclays Capital | |
| 07.05.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.05.20 | Novo Nordisk buy | UBS AG | |
| 06.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 17.04.20 | Novo Nordisk buy | UBS AG | |
| 15.04.20 | Novo Nordisk buy | UBS AG | |
| 15.04.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 15.04.20 | Novo Nordisk Outperform | Bernstein Research | |